The risk of Copaxone, particularly related to injection site reactions, includes potential damage to your skin.
Copaxone Injection Site Risks
Copaxone (glatiramer acetate) is often administered via subcutaneous injection, and this method of delivery carries some specific risks to the skin at the injection site. These risks include:
- Lipoatrophy: Damage to the fatty tissue just under the skin's surface can occur. This damage results in a visible "dent" at the injection site, which may be permanent.
- Skin Necrosis: In rare cases, death of skin tissue (necrosis) can occur at the injection site.
These potential skin-related adverse effects are important to consider when using Copaxone for treatment.
